|
TMEM128 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.357800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.523900E-03 |
| Normal-vs-Stage2 |
2.540200E-02 |
| Normal-vs-Stage3 |
3.802400E-03 |
| Normal-vs-Stage4 |
3.324700E-03 |
| Stage1-vs-Stage2 |
5.276400E-01 |
| Stage1-vs-Stage3 |
3.791200E-01 |
| Stage1-vs-Stage4 |
2.616200E-01 |
| Stage2-vs-Stage3 |
9.987400E-01 |
| Stage2-vs-Stage4 |
7.544800E-01 |
| Stage3-vs-Stage4 |
6.859200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.003100E-03 |
| Normal-vs-AfricanAmerican |
4.661900E-02 |
| Normal-vs-Asian |
6.461900E-02 |
| Caucasian-vs-AfricanAmerican |
8.087200E-01 |
| Caucasian-vs-Asian |
4.740000E-01 |
| AfricanAmerican-vs-Asian |
5.070600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.189810E-02 |
| Normal-vs-Female |
3.584300E-03 |
| Male-vs-Female |
8.637800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.247600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.536800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.983000E-04 |
| Normal-vs-Age(81-100Yrs) |
4.345800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.637800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.512370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.851800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.261800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.525800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.676600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.595000E-01 |
| Classical-VS-Follicular |
2.947600E-01 |
| Classical-VS-Other |
3.974200E-01 |
| Classical-VS-Normal |
1.757610E-02 |
| Tall-VS-Follicular |
9.776200E-01 |
| Tall-VS-Other |
6.835400E-01 |
| Tall-VS-Normal |
3.588400E-02 |
| Follicular-VS-Other |
7.153200E-01 |
| Follicular-VS-Normal |
1.217960E-02 |
| Other-VS-Normal |
9.939700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.716000E-03 |
| Normal-vs-N1 |
3.144100E-03 |
| N0-vs-N1 |
4.360800E-01 |
|
|
